A coalition of employer and consumer groups is urging the Trump administration to crack down on alleged abuse of the No Surprises Act’s independent dispute resolution process.
The post 48 Groups Want Trump Administration To Improve Process to Resolve Payer-Provider Disputes appeared first on MedCity News.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
